237 related articles for article (PubMed ID: 17256055)
21. Biology of urothelial tumorigenesis: insights from genetically engineered mice.
Wu XR
Cancer Metastasis Rev; 2009 Dec; 28(3-4):281-90. PubMed ID: 20012171
[TBL] [Abstract][Full Text] [Related]
22. Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner.
Yoo LI; Liu DW; Le Vu S; Bronson RT; Wu H; Yuan J
Cancer Res; 2006 Feb; 66(4):1929-39. PubMed ID: 16488991
[TBL] [Abstract][Full Text] [Related]
23. Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
Yee CH; Zheng Z; Shuman L; Yamashita H; Warrick JI; Wu XR; Raman JD; DeGraff DJ
Sci Rep; 2019 Jan; 9(1):270. PubMed ID: 30670749
[TBL] [Abstract][Full Text] [Related]
24. Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation.
Robinson JP; VanBrocklin MW; Guilbeault AR; Signorelli DL; Brandner S; Holmen SL
Oncogene; 2010 Jan; 29(3):335-44. PubMed ID: 19855433
[TBL] [Abstract][Full Text] [Related]
25. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
26. p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.
Piaton E; Casalegno JS; Advenier AS; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A; Mekki Y
Cancer Cytopathol; 2014 Oct; 122(10):760-9. PubMed ID: 25069600
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence.
Li H; Wang W; Liu X; Paulson KE; Yee AS; Zhang X
Oncogene; 2010 Sep; 29(36):5083-94. PubMed ID: 20581871
[TBL] [Abstract][Full Text] [Related]
28. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
[TBL] [Abstract][Full Text] [Related]
29. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
[TBL] [Abstract][Full Text] [Related]
30. Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors.
Haferkamp S; Scurr LL; Becker TM; Frausto M; Kefford RF; Rizos H
J Invest Dermatol; 2009 Aug; 129(8):1983-91. PubMed ID: 19212341
[TBL] [Abstract][Full Text] [Related]
31. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
32. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
Wang Y; Zhang Z; Lubet R; You M
Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
[TBL] [Abstract][Full Text] [Related]
33. p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.
Schneller D; Machat G; Sousek A; Proell V; van Zijl F; Zulehner G; Huber H; Mair M; Muellner MK; Nijman SM; Eferl R; Moriggl R; Mikulits W
Hepatology; 2011 Jul; 54(1):164-72. PubMed ID: 21452288
[TBL] [Abstract][Full Text] [Related]
34. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
[TBL] [Abstract][Full Text] [Related]
35. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
36. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
37. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
[TBL] [Abstract][Full Text] [Related]
38. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
Wang XJ; Greenhalgh DA; Roop DR
Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
[TBL] [Abstract][Full Text] [Related]
39. A novel role for drebrin in regulating progranulin bioactivity in bladder cancer.
Xu SQ; Buraschi S; Morcavallo A; Genua M; Shirao T; Peiper SC; Gomella LG; Birbe R; Belfiore A; Iozzo RV; Morrione A
Oncotarget; 2015 May; 6(13):10825-39. PubMed ID: 25839164
[TBL] [Abstract][Full Text] [Related]
40. PKM2 Is Essential for Bladder Cancer Growth and Maintenance.
Xia Y; Wang X; Liu Y; Shapiro E; Lepor H; Tang MS; Sun TT; Wu XR
Cancer Res; 2022 Feb; 82(4):571-585. PubMed ID: 34903602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]